Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Cash from Financing Activities (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Cash from Financing Activities for 10 consecutive years, with -$417000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 22.92% to -$417000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $24.0 million, a 54.88% decrease, with the full-year FY2025 number at $24.0 million, down 54.88% from a year prior.
  • Cash from Financing Activities was -$417000.0 for Q4 2025 at Orthopediatrics, down from -$282000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $108.3 million in Q3 2022 to a low of -$4.3 million in Q2 2024.
  • A 5-year average of $11.0 million and a median of -$33500.0 in 2021 define the central range for Cash from Financing Activities.
  • Biggest YoY gain for Cash from Financing Activities was 390220.0% in 2024; the steepest drop was 1491.67% in 2024.
  • Orthopediatrics' Cash from Financing Activities stood at -$34000.0 in 2021, then fell by 2.94% to -$35000.0 in 2022, then soared by 26920.0% to $9.4 million in 2023, then tumbled by 105.76% to -$541000.0 in 2024, then increased by 22.92% to -$417000.0 in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Cash from Financing Activities are -$417000.0 (Q4 2025), -$282000.0 (Q3 2025), and $24.8 million (Q2 2025).